SEARCH

SEARCH BY CITATION

References

  • 1
    Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356: 147152.
  • 2
    Kasiske BL, Cangro CB, Hariharan S et al. The evaluation of renal transplantation candidates: Clinical practice guidelines. Am J Transplant 2001; 1(Suppl 2): 395.
  • 3
    McCullough PA. Evaluation and treatment of coronary artery disease in patients with end-stage renal disease. Kidney Int Suppl 2005; S51S58.
  • 4
    Reslerova M, Moe SM. Vascular calcification in dialysis patients: Pathogenesis and consequences. Am J Kidney Dis 2003; 41: S96S99.
  • 5
    Landray MJ, Thambyrajah J, McGlynn FJ et al. Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis 2001; 38: 537546.
  • 6
    Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11: 12771285.
  • 7
    Kasiske BL, Malik MA, Herzog CA. Risk-stratified screening for ischemic heart disease in kidney transplant candidates. Transplantation 2005; 80: 815820.
  • 8
    Metcalfe W, Khan IH, Prescott GJ, Simpson K, MacLeod AM. End-stage renal disease in Scotland: Outcomes and standards of care. Kidney Int 2003; 64: 18081816.
  • 9
    Scottish renal registry. Available from: http://www.srr.scot.nhs.uk. Accessed November 2, 2007.
  • 10
    Mark PB, Johnston N, Groenning BA et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 2006; 69: 18391845.
  • 11
    Doan AE, Peterson DR, Blackmon JR, Bruce RA. Myocardial ischemia after maximal exercise in healthy men. A method for detecting potential coronary heart disease? Am Heart J 1965; 69: 1121.
  • 12
    Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 2003; 17: 323329.
  • 13
    Kern MJ, Lerman A, Bech JW et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: A scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation 2006; 114: 13211341.
  • 14
    De Lima JJ, Sabbaga E, Vieira ML et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 2003; 42: 263268.
  • 15
    Boden WE, O'Rourke RA, Teo KK et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 15031516.
  • 16
    Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 17251730.
  • 17
    Fleisher LA, Beckman JA, Brown KA et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116: e418e499.
  • 18
    Sharma R, Pellerin D, Gaze DC et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant 2005; 20: 22072214.